tiprankstipranks
BriaCell Therapeutics (BCTX)
:BCTX
US Market

BriaCell Therapeutics (BCTX) Dividend Date & History

Compare
233 Followers
BriaCell Therapeutics (BCTX) has no upcoming dividends

Dividend Amount Per Share​

Currently, no data available
Please return soon. This page is being updated.

BCTX Dividend Yield Range

Currently, no data available
Please return soon. This page is being updated.

BCTX Dividend History

Ex-Date
Record Date
Payment Date
Frequency
Declaration Date
Amount
Sep 05, 2023Aug 31, 2023Sep 05, 2023Not Available$0.06
The table shows BriaCell Therapeutics’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

Does BriaCell Therapeutics pay dividends?
Yes, BCTX has paid a dividend within the past 12 months.
    How much is BriaCell Therapeutics's dividend?
    BriaCell Therapeutics (BCTX) does not pay a dividend
    When is BriaCell Therapeutics ex-dividend date?
    BriaCell Therapeutics's previous ex-dividend date was on Sep 05, 2023. BriaCell Therapeutics shareholders who own BCTX stock before this date received BriaCell Therapeutics's last dividend payment of $0.06 per share on Sep 05, 2023. BCTX's next ex-dividend date has not been announced yet.
      When is BriaCell Therapeutics dividend payment date?
      BriaCell Therapeutics’s next quarterly payment date is on Sep 05, 2023, when BriaCell Therapeutics shareholders who owned BCTX shares before Sep 05, 2023 received a dividend payment of $0.06 per share. Add BCTX to your watchlist to be reminded of BCTX's next dividend payment.
        Does BriaCell Therapeutics have sufficient earnings to cover their dividend?
        The BriaCell Therapeutics has paid a dividend in the last year and may provide dividends in the near future.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis